Positron emission tomography and circulating tumor cells to monitor a dramatic response to Gefitinib

Journal of Thoracic Oncology

Volumn 7, Issue 11, 2012, Pages

  Morabito, Alessandro ^a   Sandomenico, Claudia ^a   Costanzo, Raffaele ^a   Montanino, Agnese ^a   Caraco, Corradina ^b   De Lutio, Elisabetta ^b   Bevilacqua, Simona ^b   Pasquale, Raffaella ^c   Caronna, Antonietta ^d   Botti, Gerardo ^b   Normanno, Nicola ^b,c   Rocco, Gaetano ^b  

^a NATIONAL CANCER INSTITUTE   (Italy)

^b NATIONAL CANCER INSTITUTE   (Italy)

^c Centro di Ricerche Oncologiche di Mercogliano CROM   (Italy)

^d Division of Cardiology   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTITHROMBIN III; CORTICOSTEROID; DIURETIC AGENT; EPIDERMAL GROWTH FACTOR RECEPTOR; FLUORODEOXYGLUCOSE F 18; FRESH FROZEN PLASMA; GEFITINIB; LOW MOLECULAR WEIGHT HEPARIN;

ADULT; BLOOD ANALYSIS; BLOOD SAMPLING; CANCER CHEMOTHERAPY; CANCER CYTODIAGNOSIS; CANCER PATIENT; CASE REPORT; CIRCULATING TUMOR CELL; COMPUTER ASSISTED EMISSION TOMOGRAPHY; CYTOLOGY; DISSEMINATED INTRAVASCULAR CLOTTING; DRUG UPTAKE; EXON; GENE MUTATION; GENETIC ASSOCIATION; HUMAN; KIDNEY FAILURE; LIVER FAILURE; LIVER METASTASIS; LUNG ADENOCARCINOMA; LUNG NODULE; MALE; MUTATIONAL ANALYSIS; NOTE; PERICARDIAL EFFUSION; PLEURA EFFUSION; POLYMERASE CHAIN REACTION; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; SURGICAL DRAINAGE; TREATMENT RESPONSE; TUMOR CELL;

EID: 84867879786     PISSN: 15560864     EISSN: 15561380     Source Type: Journal    
DOI: 10.1097/JTO.0b013e3182653da2     Document Type: Article

References (5)

1. Takahashi R, Hirata H, Tachibana I, et al. Early [18F]fuorodeoxyglucose positron emission tomography at two days of geftinib treatment predicts clinical outcome in patients with adenocarcinoma of the lung. Clin Cancer Res 2012;18:220-228.
2. Krebs MG, Sloane R, Priest L, et al. Evaluation and prognostic signif-cance of circulating tumor cells in patients with non-small-cell lung cancer. J Clin Oncol 2011;29:1556-1563.
3. Costanzo R, Piccirillo MC, Sandomenico C, et al. Geftinib in non small cell lung cancer. J Biomed Biotechnol 2011;2011:815269.
4. Inoue A, Kobayashi K, Usui K, et al.; North East Japan Geftinib Study Group. First-line geftinib for patients with advanced non-small-cell lung cancer harboring epidermal growth factor receptor mutations without indication for chemotherapy. J Clin Oncol 2009;27:1394-1400.
5. Maheswaran S, Sequist LV, Nagrath S, et al. Detection of mutations in EGFR in circulating lung-cancer cells. N Engl J Med 2008;359:366-377.